Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

LY75 modulates epithelial to mesenchymal transition and metastatic potential of ovarian cancer cells


ABSTRACT: Epithelial ovarian cancer (EOC) accounts for 4% of all cancers in women and is the leading cause of death from gynecologic malignancies. It is well established that cancer invasion and metastasis still represent the major causes of the failure of cancer treatment. Previously, we identified the mannose receptor LY75 (DEC205/CD205) gene as notably hypomethylated in high-grade (HG) serous epithelial ovarian tumors, compared to normal ovarian tissues. LY75 has been identified as a putative antigen-uptake receptor, which is expressed abundantly on dendritic cells, which are specialist antigen presenting cells to T lymphocytes for the initiation of an immune response. The implication of LY75 in EOC tumorigenesis is currently unknown. Here we show that LY75 is strongly overexpressed in HG serous EOC tumors as compared to normal ovarian tissue. Importantly, shRNA-mediated LY75 knockout in the mesenchymal EOC cells (SKOV3) led to mesenchymal to epithelial transition (MET), associated with overexpression of epithelial markers E-cadherin and EPCAM and loss of expression of mesenchymal markers Fibronectin, N-cadherin Snail1 and Twist1. In addition, LY75 suppression significantly inhibited EOC cell migration and invasion in vitro. However, LY75 knockdown led to enhanced tumor cell dissemination and significantly increased lethality in vivo, in xenograft model of advanced peritoneal EOC. Thus, our findings indicate that LY75 could play an essential role in the mesenchymal-to-epithelial transition (MET) of EOC cells and support the hypothesis that, while epithelial-to-mesenchymal transition (EMT) enables the invasiveness of tumor cells, a MET-associated epithelial phenotype could be essential for their metastatic colonization. To better understand the molecular mechanisms of LY75 gene action in epithelial ovarian cancer (EOC), we employed the Agilent Whole Human Genome microarrays, containing ~ 44,000 genes to identify global gene expression changes upon LY75 suppression in SKOV3 EOC cells. We compared the gene expression of the previously selected shRNA-mediated LY75-knockdown clones sh-S3 and sh-S6 against the corresponding control (ctrl) clone. The microarray experiments were performed in duplicates, as two hybridizations were carried out for each of the LY75-suppressing cell clone against the corresponding control, using a fluorescent dye reversal (dye-swap) technique.

ORGANISM(S): Homo sapiens

SUBMITTER: Dimcho Bachvarov 

PROVIDER: E-GEOD-74711 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.

Faddaoui Adnen A   Bachvarova Magdalena M   Plante Marie M   Gregoire Jean J   Renaud Marie-Claude MC   Sebastianelli Alexandra A   Gobeil Stephane S   Morin Chantale C   Macdonald Elizabeth E   Vanderhyden Barbara B   Bachvarov Dimcho D  

Oncotarget 20160301 12


The molecular basis of epithelial ovarian cancer (EOC) dissemination is still poorly understood. Previously, we identified the mannose receptor LY75 gene as hypomethylated in high-grade (HG) serous EOC tumors, compared to normal ovarian tissues. LY75 represents endocytic receptor expressed on dendritic cells and so far, has been primarily studied for its role in antigen processing and presentation. Here we demonstrate that LY75 is overexpressed in advanced EOC and that LY75 suppression induces m  ...[more]

Similar Datasets

2013-09-23 | E-GEOD-46477 | biostudies-arrayexpress
2016-04-01 | GSE74711 | GEO
2017-10-22 | GSE98737 | GEO
2014-05-22 | E-GEOD-52602 | biostudies-arrayexpress
2023-05-31 | E-MTAB-12150 | biostudies-arrayexpress
2018-02-13 | GSE104295 | GEO
2012-05-11 | E-GEOD-37934 | biostudies-arrayexpress
2011-12-12 | E-GEOD-31433 | biostudies-arrayexpress
2016-02-25 | E-GEOD-71017 | biostudies-arrayexpress
| PRJNA596535 | ENA